VITA — Vitaminka AD Prilep Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMicro CapContrarian

Annual income statement for Vitaminka AD Prilep, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	—	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,283	2,351	2,824	3,812	3,247
Cost of Revenue
Gross Profit	765	805	795	865	1,081
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,233	2,285	2,704	3,700	3,069
Operating Profit	50.2	66.5	120	112	178
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	19.9	29.3	83.2	75.3	109
Provision for Income Taxes
Net Income After Taxes	18.1	25.8	76.2	69.8	99.3
Net Income Before Extraordinary Items
Net Income	18.1	25.8	76.2	69.8	99.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	18.1	25.8	76.2	69.8	99.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	263	362	953	939	1,267
Dividends per Share